Iqgenetix LLC

Iqgenetix LLC was paid $458K by Medicaid between Feb 2021 and May 2023, across 30 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 58% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#26 of 78

Median peer was paid$37K

This provider vs. median12×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	4,547	$66K
2022	22,580	$360K
2023	1,640	$32K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	58%	8,865	2,622	$266K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	25%	1,596	1,088	$113K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.8%	8,314	2,363	$36K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.0%	542	358	$9K
87481		1.4%	884	607	$7K
87529		<1%	245	155	$4K
87486		<1%	534	358	$4K
87581		<1%	535	358	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	584	450	$3K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	247	157	$2K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	246	156	$2K
87632		<1%	628	428	$1K

18 more codes

87641		<1%	591	$1K
87653		<1%	528	$967.27
87150		<1%	584	$879.86
87640		<1%	592	$828.41
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	139	$492.78
87498		<1%	564	$414.42
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	249	$403.75
87625		<1%	247	$400.82
87623		<1%	247	$339.31
87505		<1%	24	$307.89
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	54	$211.14
81001		<1%	485	$87.61
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	121	$84.31
87500		<1%	74	$84.21
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	170	$77.20
87563		<1%	248	$70.00
87501		<1%	512	$44.53
87634		0%	118	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOHLER, JEFFREY (CEO)